Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasonic Drug Delivery of Cefazolin for ABSSSI in Chronic Wounds
NCT03732365Phase 2Unknown
- Start
- Feb 2019
- Primary completion
- Jan 2020
- Modality
- Reversible Covalent Inhibitors
01
Overview
A Phase 2 trial of cefazolin in acute bacterial skin and skin structure infection (ABSSSI). Status: unknown.
02
Drugs
cefazolin
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT03732365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03732365.